← Back to Search

Behavioral Intervention

1 for Parkinson's Disease

N/A
Waitlist Available
Research Sponsored by Amy Farabaugh, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up screen, week 4, week 8, week 12; if applicable, week 16, week 20, week 24
Awards & highlights

Study Summary

The purpose of the study is to examine the effects of a form of talk therapy called cognitive behavior therapy (CBT) in the treatment of major depression in individuals with Parkinson's disease (PD).

Eligible Conditions
  • Parkinson's Disease
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screen, week 4, week 8, week 12; if applicable, week 16, week 20, week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and screen, week 4, week 8, week 12; if applicable, week 16, week 20, week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Response according to the Hamilton Rating Scale for Depression, 17 items (HAM-D 17).

Side effects data

From 2021 Phase 4 trial • 12 Patients • NCT04135937
8%
irritability
100%
80%
60%
40%
20%
0%
Study treatment Arm
MESH

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Patients randomized to the immediate arm will be given 12 weeks of CBT starting one week after randomization
Group II: 2Active Control1 Intervention
Patients in the delayed arm will receive 12 weeks of CBT, starting 12 weeks after randomization.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioral Therapy
2016
Completed Phase 4
~3120

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalOTHER
1,614 Previous Clinical Trials
11,470,755 Total Patients Enrolled
Beth Israel Deaconess Medical CenterOTHER
837 Previous Clinical Trials
13,010,192 Total Patients Enrolled
Amy Farabaugh, PhDLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Psychosocial Treatment of Depression in Parkinson's Disease
Amy Farabaugh, PhD 2007. "Psychosocial Treatment of Depression in Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00853346.
All > Parkinson
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top